MXPA03000001A - Nuevo metodo para obtener formulaciones acuosas con principios activos susceptibles a oxidacion y las soluciones acuosas obtenidas de este modo. - Google Patents
Nuevo metodo para obtener formulaciones acuosas con principios activos susceptibles a oxidacion y las soluciones acuosas obtenidas de este modo.Info
- Publication number
- MXPA03000001A MXPA03000001A MXPA03000001A MXPA03000001A MXPA03000001A MX PA03000001 A MXPA03000001 A MX PA03000001A MX PA03000001 A MXPA03000001 A MX PA03000001A MX PA03000001 A MXPA03000001 A MX PA03000001A MX PA03000001 A MXPA03000001 A MX PA03000001A
- Authority
- MX
- Mexico
- Prior art keywords
- ppm
- inert gas
- active principles
- aqueous formulations
- obtaining
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0005—Degasification of liquids with one or more auxiliary substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Removal Of Specific Substances (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
La invencion se refiere el campo de la quimica organica y mas particularmente a aquel de la quimica terapeutica. Mas precisamente, esta se refiere a un metodo para obtener formulaciones acuosas de principios activos facilmente oxidables, en particular fenoles, estables en un periodo prolongado, el cual consiste en que se someten a desoxigenacion por burbujeo con un gas inerte y/o se someten al vacio, mientras que se protegen contra posible captacion de oxigeno al mantenerlas bajo atmosfera de gas inerte, en llenado bajo las inerte en embotellas previamente libres de aire por burbujeo de gas inerte, luego sometiendolas cuando estan siendo cerradas a un vacio, para obtener en una botella una presion no mayor de 65,000 Pa, mediante lo cual se obtienen solutos que tienen una concentracion residual de oxigeno en la solucion, menor de 2 ppm, y preferentemente del orden de 1 ppm e incluso de 0.5 ppm. La invencion es util en particular para elaborar preparaciones de inyeccion que tienen un contenido de oxigeno la solucion, menor de 2 ppm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007231A FR2809619B1 (fr) | 2000-06-06 | 2000-06-06 | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
PCT/FR2001/001749 WO2001093830A1 (fr) | 2000-06-06 | 2001-06-06 | Procede d'obtention de formulations aqueuses de principes actifs sensibles a l'oxydation |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03000001A true MXPA03000001A (es) | 2004-03-19 |
Family
ID=8851012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03000001A MXPA03000001A (es) | 2000-06-06 | 2001-06-06 | Nuevo metodo para obtener formulaciones acuosas con principios activos susceptibles a oxidacion y las soluciones acuosas obtenidas de este modo. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6992218B2 (es) |
CN (1) | CN1556694A (es) |
AP (1) | AP1880A (es) |
AU (1) | AU2001266120A1 (es) |
CA (1) | CA2415403C (es) |
CZ (1) | CZ200313A3 (es) |
DZ (1) | DZ3384A1 (es) |
FR (1) | FR2809619B1 (es) |
MA (1) | MA26926A1 (es) |
MX (1) | MXPA03000001A (es) |
NZ (1) | NZ523458A (es) |
PE (1) | PE20030508A1 (es) |
RU (1) | RU2003100090A (es) |
TW (1) | TWI237570B (es) |
WO (1) | WO2001093830A1 (es) |
YU (1) | YU103A (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
ITMI20012135A1 (it) | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
FR2832063B1 (fr) * | 2001-11-15 | 2004-08-27 | Aguettant Lab | Procede de production de solutions stables de substances phenoliques et les solutions en resultant |
FR2851164B1 (fr) | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
US20050020554A1 (en) * | 2003-06-06 | 2005-01-27 | Ahmed Salah U. | Stability of hormone formulations |
FR2880807B1 (fr) * | 2005-01-19 | 2007-04-13 | Aguettant Sa Lab | Composition pharmaceutique injectable |
KR20070104931A (ko) | 2005-02-09 | 2007-10-29 | 마커사이트, 인코포레이티드 | 안구 치료용 제제 |
DE102005037653A1 (de) * | 2005-08-05 | 2007-02-15 | Theraselect Gmbh | Stabile, flüssige Formulierung von Paracetamol |
US20070077303A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
FR2894154B1 (fr) * | 2005-12-06 | 2008-03-14 | Pharmatop Scr | Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation. |
CA2635797C (en) * | 2006-02-09 | 2015-03-31 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
DK2001466T3 (en) | 2006-03-23 | 2016-02-29 | Santen Pharmaceutical Co Ltd | LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
CA2628806C (en) * | 2006-07-18 | 2012-08-21 | Genfarma Laboratorio S.L. | Injectable liquid paracetamol formulation |
EP1992334A1 (en) * | 2007-05-08 | 2008-11-19 | Docpharma NV/SA | Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation |
DE102007026975A1 (de) * | 2007-06-01 | 2008-12-04 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Antioxidationsmittel für Lebensmittel |
AR067047A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
AR067048A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
CA2705733C (en) * | 2007-11-13 | 2015-02-03 | Cadence Pharmaceuticals | Reduced dose intravenous acetaminophen |
EP2307056B1 (en) * | 2008-01-17 | 2021-12-15 | Pharmis Biofarmacêutica, LDA | Stabilized aqueous formulation containing paracetamol |
FR2926992B1 (fr) * | 2008-02-06 | 2011-01-14 | Moly Pharma | Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution |
US20110097470A1 (en) * | 2008-06-11 | 2011-04-28 | Joerg Kowalczyk | Highly active antioxidant based on trehalulose |
EP2243477A1 (de) * | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol zur parenteralen Verabreichung |
US8404748B2 (en) | 2009-08-13 | 2013-03-26 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
EP2464332B1 (en) | 2009-08-13 | 2016-03-02 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
AU2009353168B2 (en) | 2009-09-24 | 2014-09-04 | Kabushiki Kaisha Toshiba | Carbon dioxide gas absorbent solution |
CN102711726A (zh) | 2009-12-10 | 2012-10-03 | 特克尼梅德医疗技术股份公司 | 用于制备扑热息痛稳定液体制剂的方法和组合物 |
US20110207824A1 (en) * | 2010-02-25 | 2011-08-25 | Moly Pharma | Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution |
EP2672955A1 (en) | 2011-02-10 | 2013-12-18 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
PT2680832T (pt) | 2011-03-04 | 2019-10-28 | Gruenenthal Gmbh | Formulação farmacêutica aquosa de tapentadol para administração oral |
ES2414557B1 (es) * | 2012-01-16 | 2014-06-10 | Novocat Farma, S.A. | Composición acuosa de paracetamol para inyección |
ITMI20121154A1 (it) | 2012-06-29 | 2013-12-30 | Sint Sa | Soluzione iniettabile di acetaminofene per la somministrazione spinale |
CN103006550A (zh) * | 2012-12-11 | 2013-04-03 | 哈药集团三精制药股份有限公司 | 一种胞磷胆碱钠注射液及其制备方法 |
US20140303254A1 (en) * | 2013-04-08 | 2014-10-09 | InnoPharma Licensing LLC | Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation |
UY35988A (es) | 2014-02-27 | 2015-09-30 | Sint Sa | Proceso para la producción de una solución inyectable de noradrenalina de baja concentración |
BR102014005885B1 (pt) | 2014-03-13 | 2021-04-13 | Biotec Biológica Indústria Farmacêutica Ltda E.P.P | Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso |
WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
CN104288099B (zh) * | 2014-09-25 | 2017-02-15 | 西安仁仁药业有限公司 | 一种布洛芬注射液的制备方法 |
PT3479823T (pt) | 2015-03-27 | 2020-09-29 | Gruenenthal Gmbh | Formulação estável para administração parentérica de tapentadol |
NO3106148T3 (es) | 2015-06-18 | 2018-08-11 | ||
GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
EP3120837A1 (de) | 2015-07-22 | 2017-01-25 | Stada Arzneimittel Ag | Verfahren zur herstellung einer bortezomibester-lösung |
AU2017215419B2 (en) | 2016-02-05 | 2019-11-21 | Innopharma, Inc. | Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation |
MX2019003257A (es) | 2016-09-23 | 2019-06-10 | Gruenenthal Gmbh | Formulacion estable para la administracion parenteral de tapentadol. |
WO2018140894A1 (en) | 2017-01-30 | 2018-08-02 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
WO2018192664A1 (en) * | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
WO2019150381A1 (en) * | 2018-02-01 | 2019-08-08 | Joshi Mahendra R | A stable pharmaceutical composition and process for production of isoproterenol hydrochloride injection |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
CA3100314A1 (en) | 2018-05-16 | 2019-11-21 | Bayer Healthcare Llc | High concentration suspension formulation for cold and flu soft gel capsule medications |
EP3863589A1 (en) * | 2018-10-08 | 2021-08-18 | Merz Pharma GmbH & Co. KGaA | Neurotoxin prefilled vial |
US10478453B1 (en) | 2019-01-15 | 2019-11-19 | Exela Pharma Sciences, LLC | Stable, highly pure L-cysteine compositions for injection and methods of use |
CN113105040A (zh) * | 2021-04-02 | 2021-07-13 | 武汉工控工业技术研究院有限公司 | 一种自然水体无菌处理及长期保存技术 |
CN116803376B (zh) * | 2023-08-04 | 2024-02-13 | 广州白云山星群(药业)股份有限公司 | 一种复方愈创木酚磺酸钾口服溶液的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3443004A (en) * | 1965-04-08 | 1969-05-06 | Ciba Geigy Corp | Injectable solution containing 6-chloroor 6-trifluoromethyl-7-sulfamyl - 1,2,4-benzothiodiazine-1,1-dioxide diuretic |
DD153578A1 (de) * | 1980-10-22 | 1982-01-20 | Hans Meffert | Stabilisierung von oxydationsempfindlichen wirkstoffen,vorrangig dithranol in arzneizubereitungen |
RO93391B (ro) * | 1984-12-20 | 1988-03-31 | Eli Lilly And Company | Procedeu pentru prepararea unor saruri de dobutamina |
WO1994008602A1 (en) * | 1992-10-21 | 1994-04-28 | Alcon Laboratories, Inc. | Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
WO1994013274A1 (en) * | 1992-12-10 | 1994-06-23 | Abbott Laboratories | Stabilized catecholamine solutions |
FR2740338B1 (fr) * | 1995-12-01 | 1997-12-05 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees contenant de la dobutamine |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
-
2000
- 2000-06-06 FR FR0007231A patent/FR2809619B1/fr not_active Expired - Lifetime
-
2001
- 2001-06-06 CZ CZ200313A patent/CZ200313A3/cs unknown
- 2001-06-06 MX MXPA03000001A patent/MXPA03000001A/es active IP Right Grant
- 2001-06-06 US US10/332,060 patent/US6992218B2/en not_active Expired - Lifetime
- 2001-06-06 DZ DZ013384A patent/DZ3384A1/xx active
- 2001-06-06 CN CNA018136702A patent/CN1556694A/zh active Pending
- 2001-06-06 AU AU2001266120A patent/AU2001266120A1/en not_active Abandoned
- 2001-06-06 AP APAP/P/2002/002711A patent/AP1880A/en active
- 2001-06-06 RU RU2003100090/15A patent/RU2003100090A/ru not_active Application Discontinuation
- 2001-06-06 YU YU103A patent/YU103A/sh unknown
- 2001-06-06 CA CA2415403A patent/CA2415403C/fr not_active Expired - Lifetime
- 2001-06-06 WO PCT/FR2001/001749 patent/WO2001093830A1/fr active IP Right Grant
- 2001-06-06 NZ NZ523458A patent/NZ523458A/en not_active IP Right Cessation
- 2001-07-16 PE PE2001000715A patent/PE20030508A1/es not_active Application Discontinuation
- 2001-07-31 TW TW090118576A patent/TWI237570B/zh not_active IP Right Cessation
-
2003
- 2003-01-03 MA MA26990A patent/MA26926A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2415403A1 (fr) | 2001-12-13 |
FR2809619B1 (fr) | 2004-09-24 |
US20040054012A1 (en) | 2004-03-18 |
NZ523458A (en) | 2005-08-26 |
AP2002002711A0 (en) | 2002-12-31 |
MA26926A1 (fr) | 2004-12-20 |
FR2809619A1 (fr) | 2001-12-07 |
WO2001093830A1 (fr) | 2001-12-13 |
DZ3384A1 (fr) | 2001-12-13 |
AP1880A (en) | 2008-08-19 |
TWI237570B (en) | 2005-08-11 |
AU2001266120A1 (en) | 2001-12-17 |
US6992218B2 (en) | 2006-01-31 |
YU103A (sh) | 2006-05-25 |
CA2415403C (fr) | 2011-05-24 |
RU2003100090A (ru) | 2004-05-10 |
PE20030508A1 (es) | 2003-06-25 |
CZ200313A3 (cs) | 2003-11-12 |
CN1556694A (zh) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03000001A (es) | Nuevo metodo para obtener formulaciones acuosas con principios activos susceptibles a oxidacion y las soluciones acuosas obtenidas de este modo. | |
ES2216965T3 (es) | Procedimiento para el tratamiento y la extraccion de compuestos organicos del corcho mediante un fluido denso bajo presion. | |
HRP20060089B1 (en) | Method for the stabilization of atorvastatin | |
DE69616765T2 (de) | Verfahren und Vorrichtung zum Einführen eines ein Aroma enthaltenden Inertgases in das Totvolumen einer Lebensmittelpackung | |
ES2076646T3 (es) | Procedimiento para el llenado de botellas o de recipientes similares con un material liquido a envasar asi como un dispositivo para la realizacion de este procedimiento. | |
MXPA03005679A (es) | Alimentador y metodo para preparar soluciones acuosas que contienen altas concentraciones de oxidantes solidos. | |
CA2664952A1 (en) | Method of manufacturing tea drink | |
AU2002234448A1 (en) | A method of processing roasted coffee | |
Scheffer | O2 requirements for growth and survival of wood-decaying and sapwood-staining fungi | |
WO2003082353A3 (en) | Method and system for processing bio-contaminated articles | |
TNSN05029A1 (en) | Cork product treatment system and apparatuses by extraction of compounds dragged in water vapour | |
IT1201997B (it) | Procedimento per la sanitizzazione di contenitori e materiali di confezionamento, particolarmente per uso farmaceutico e cosmetico, ed impianto per effettuare il procedimento | |
WO2003037388A3 (en) | System and method for de-contaminating and/or sanitizing | |
WO2005044315B1 (en) | Method for sterilization using ethylene oxide | |
IL139465A0 (en) | Method for prolonged storage of dna molecules and packaging implementing said method | |
DK0591852T3 (da) | Produkt med nedsat H2S-indhold og fremgangsmåde til fremstilling deraf | |
WO2002026059A3 (en) | Method for preserving food products using biological modified atmosphere packaging | |
WO2008054198A3 (en) | Packaging and method for storing of living crustaceans and shellfish | |
SE9402119D0 (sv) | Solution | |
EP1099977A3 (en) | Preparation method of photothermographic material | |
CA2789379A1 (en) | Method of packaging fresh meat products in a low oxygen environment, meat color improvement solution and pre-packaged food product | |
KR200400408Y1 (ko) | 살균 및 제독기능과 맛을 향상시키는 병뚜껑 | |
JPS5779847A (en) | Penetration of effective food into food | |
AU2001100034A4 (en) | Oak addition to bottled wine. | |
CA2489738A1 (en) | Modified atmosphere packaging for seafood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |